• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOLTON MEDICAL, INC. TREO ABDOMINAL STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOLTON MEDICAL, INC. TREO ABDOMINAL STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC Back to Search Results
Catalog Number 28-L2-09-120U
Device Problems Obstruction of Flow (2423); Patient Device Interaction Problem (4001)
Patient Problems Obstruction/Occlusion (2422); Thromboembolism (2654); Thrombosis/Thrombus (4440)
Event Date 01/22/2024
Event Type  Injury  
Event Description
"occlusion: evar was performed for an abdominal aortic aneurysm of approximately 60mm.Ct scan on (b)(6) 2023 showed no problems, but the patient came to the hospital with leg pain beginning around december 25.Ct scan showed that the treo leg extension stent-graft was occluded from the central to the peripheral.On (b)(6) 2024, thrombectomy was performed using a fogarty (edwards lifesciences), and a bare stent was additionally implanted.Physician's comment: additional treatment was needed for the patient with poor cardiac function with ef15%.Please provide the details of the cases and the incidence of the occlusion of the treo leg extension (9 mm).Operation type: evar blood loss: amount is unknown.No image available pre-case plan available no additional information available" patient outcome - "the patient was in serious condition and the outcome is unknown.".
 
Manufacturer Narrative
Bolton medical, inc.(d/b/a terumo aortic), herein known as the "company", is submitting this report pursuant to 21 cfr part 803, has made reasonable efforts to obtain complete information, and has provided as much as is available to the company as of the submission date of this report.This report is based on information obtained by the company, which may not have been able to fully investigate or verify prior to the date the report was required by the regulations.Any required fields that are unpopulated are blank because the information is currently unknown, unavailable, or not applicable.This report does not constitute an admission or a conclusion by anyone that the device caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the certain regulations, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Manufacturer Narrative
Bolton medical, inc.(d/b/a terumo aortic), herein known as the "company", is submitting this report pursuant to 21 cfr part 803, has made reasonable efforts to obtain complete information, and has provided as much as is available to the company as of the submission date of this report.This report is based on information obtained by the company, which may not have been able to fully investigate or verify prior to the date the report was required by the regulations.Any required fields that are unpopulated are blank because the information is currently unknown, unavailable, or not applicable.This report does not constitute an admission or a conclusion by anyone that the device caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the certain regulations, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
"occlusion: evar was performed for an abdominal aortic aneurysm of approximately 60mm.Ct scan on (b)(6 2023 showed no problems, but the patient came to the hospital with leg pain beginning around (b)(6).Ct scan showed that the treo leg extension stent-graft was occluded from the central to the peripheral.On ,(b)(6) 2024, thrombectomy was performed using a fogarty (edwards lifesciences), and a bare stent was additionally implanted.Physician's comment: additional treatment was needed for the patient with poor cardiac function with ef15%.Please provide the details of the cases and the incidence of the occlusion of the treo leg extension (9 mm).Operation type: evar blood loss: amount is unknown.No image available pre-case plan available no additional information available" patient outcome - "the patient was in serious condition and the outcome is unknown.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREO ABDOMINAL STENT-GRAFT SYSTEM
Type of Device
STENT, ENDOVASCULAR GRAFT, AORTIC
Manufacturer (Section D)
BOLTON MEDICAL, INC.
799 international parkway
sunrise FL 33325
Manufacturer Contact
megan indeglia
799 international parkway
sunrise, FL 33325
9548389699
MDR Report Key18627551
MDR Text Key334368831
Report Number2247858-2024-00046
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P190015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number28-L2-09-120U
Device Lot Number2107260384
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/22/2024
Initial Date FDA Received02/01/2024
Supplement Dates Manufacturer Received01/22/2024
Supplement Dates FDA Received04/03/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/20/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age99 YR
-
-